Mijn engels is normaliter vrij goed, maar deze begrijp ik niet echt ?
Is dat nu een Chinese onderzoekinstelling die Remdesivir (niet filgo, laat dat duidelijk zijn) gaat patenteren ? Ben niet goed mee...
Berichtje komt via Bolero van Reuters :
China lab seeks patent on use of Gilead's coronavirus treatment
08:10 (05/02) - Bron: Reuters
By Zhang Yan and David Stanway
BEIJING/SHANGHAI, Feb 5 (Reuters) - A state-run Chinese
research institute has applied for a patent on the use of Gilead
Sciences' experimental U.S. antiviral drug, which scientists
think could provide treatment for the coronavirus that has
killed hundreds and infected thousands.
The Wuhan Institute of Virology of the China Academy of
Sciences, based in the city where the outbreak is believed to
have originated, said in a statement on Tuesday it applied to
patent the use of Remdesivir, an antiviral drug developed by
Gilead , to treat the virus.
A study published in the New England Journal of Medicine
last week reported a coronavirus patient in the United States
was found to show an improvement after taking Remdesivir, which
is also used to treat infectious diseases such as Ebola.
The Wuhan Institute of Virology did not respond to Reuters'
request for comment.
"Even if the Wuhan Institute's application gets authorised,
the role is very limited because Gilead still owns the
fundamental patent of the drug," said Zhao Youbin, a
Shanghai-based intellectual property counsel at Purplevine IP
Service Co.
"Any exploitation of the patent must seek approval from
Gilead."
Gilead did not immediately respond to request for comment
but last week said it was working with China to test Remdesivir
for use in a small number of patients with the coronavirus.
The application was submitted jointly with the Military
Medicine Institute of the People's Liberation Army Academy of
Military Science, according to the Wuhan Institute of Virology.
Scientists from both institutes said in a paper published in
Nature's Cell Research on Tuesday that they found both
Remdesivir and Chloroquine, which is used to treat malaria, to
be an effective way to inhibit the coronavirus.
The Wuhan-based laboratory said in its statement that the
patent application was filed on Jan. 21 and aimed at protecting
China's national interests. However, it said it would
temporarily drop its patent claims if the opportunity arose to
collaborate with foreign pharmaceutical firms to fight the
epidemic.